COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. North Carolina patients with a documented clinical need may be eligible for compounded tirzepatide.
North Carolina’s Research Triangle and Charlotte metros have strong healthcare infrastructure, while western mountain and eastern coastal communities may have fewer local options. Compounding Finder helps NC residents compare licensed pharmacies.
Yes. The North Carolina Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.